CureVac N.V.
Pioneering mRNA technology for prophylactic vaccines and novel cancer immunotherapies.
CVAC | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- FRIEDRICH-MIESCHER-STRASSE 15, 72076 TUBINGEN
- Website:
- https://www.curevac.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
CureVac N.V. is a global biopharmaceutical company that pioneers transformative medicines based on messenger RNA (mRNA) technology. Founded in 2000, the company was one of the first to successfully harness mRNA for medical purposes and possesses over two decades of experience in the field. CureVac's clinical pipeline is focused on developing prophylactic vaccines for infectious diseases and novel cancer immunotherapies. The company also develops treatments that enable the body to produce its own therapeutic proteins. Through strategic collaborations, CureVac advances its proprietary mRNA platform to address a wide range of medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CureVac N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CureVac N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CureVac N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
